Totarol is a diterpene compound extracted from the totara tree. Totarol and eight other diterpenes were found to potentiate methicillin, one reducing the minimum inhibitory concentration of methicillin against resistant Staphylococcus aureus 256-fold. Totarol did not inhibit the synthesis of DNA or peptidoglycan in S. aureus, but reduced the respiration rate by 70%. Under potentiation conditions, diterpenes had only a slight effect on the respiration rate, but had a significant effect on expression of PBP 2a. We conclude that the primary staphylococcal target for totarol is the respiratory chain, but that potentiation of methicillin by diterpenes is by interference with PBP 2a expression. ß 1999 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
Introduction
Totarol is a diterpene [1] isolated from the totara tree which is native to New Zealand. Studies on many diterpenes extracted from natural sources have shown that they have intrinsic antimicrobial activity [2^6] , but the mode of action is controversial. Totarol and anacardic acid in particular have been found to possess potent activity against Gram-positive bacteria, in particular Staphylococcus aureus [7] . This makes them unique as potential chemotherapeutic agents, as very few plant-derived compounds are active against S. aureus [7] .
The mode of antibacterial action of totarol and other diterpenes is unclear. One of the earliest studies of antimicrobial diterpenoids also reported interference with the DNA polymerase of HeLa cells in tissue culture [3] , but to our knowledge, this activity has not been investigated for bacterial cells. Kobayashi and co-workers [2] used incorporation rates of radiolabelled glucosamine to demonstrate inhibition of cell wall biosynthesis in Bacillus subtilis cells treated with pisiferic acid derivatives. In contrast, Haraguchi and co-workers [6] reported in a recent study that totarol inhibited oxygen consumption and respiratory-driven proton translocation in whole cells of Micrococcus luteus, Pseudomonas aeruginosa, Escherichia coli and S. aureus.
In a preliminary report, diterpenes have been described which dramatically reduced the minimum in-hibitory concentration (MIC) of imipenem against methicillin-resistant S. aureus (MRSA) from 32 to 0.125 Wg ml 31 [8] . These diterpenes were also reported to potentiate the activity of L-lactams against MRSA in a murine soft tissue model [9] . The potentiation of the antimicrobial activity of the L-lactam was attributed to loss of expression or function of penicillin binding protein 2a (PBP 2a; [8] ). However, publication of a full study consolidating these ¢nd-ings has not occurred, partly motivating the current study.
MRSA are a major problem in hospitals due to multiple resistance to many common antibiotics [10] and they now have a world-wide distribution [11] . The expression of an altered PBP, PBP 2a, which has a very low a¤nity for L-lactam antibiotics, makes some strains of MRSA resistant to almost all drugs in this class [12] . In this paper, we describe the antibacterial properties of nine diterpenes against S. aureus, as well as the identi¢cation of four compounds with a signi¢cant ability to lower the MIC of methicillin against MRSA. We show that totarol had a negligible e¡ect on the synthesis of peptidoglycan and DNA in MRSA, but signi¢cantly inhibited respiration. The potentiation of methicillin by a diterpene derivative was independent of inhibition of respiration, but was probably due to inhibition of expression of PBP 2a by the diterpene.
Materials and methods

Bacterial strains, media and antibiotics
Two strains of S. aureus were used: strain 87 (equivalent to NCTC 6571 and ATCC 9144), used as a methicillin-sensitive S. aureus strain (MSSA), and strain MR96/164, an MRSA clinical isolate from New Zealand which was resistant to L-lactam antibiotics, were both obtained from the culture collection held at the Communicable Disease Centre, Porirua, New Zealand. S. aureus strains were cultured on tryptic soy agar plates.
The diterpenes used in this study are listed in Table 1 with their chemical names and original references. The chemical structures of the three most potent diterpenes in this study are shown in Fig. 1 . Diterpenes were synthesised according to the published procedures. A 100-mg ml 31 stock solution of methicillin was sterilised by passage through a sterile 0.45-Wm ¢lter and stored at 320³C.
Antibacterial susceptibility and potentiation tests
The MIC of compounds for S. aureus and E. coli was determined by the standard macrobroth dilution method, as described in the Manual of Clinical Microbiology [13] . The MIC was determined as being the lowest concentration of compound that resulted in complete inhibition of growth.
The extent to which compounds reduced the MIC of methicillin was investigated essentially the same way as for MIC determination. The diterpene was added to each of the test concentrations to give a ¢nal concentration of 10 Wg ml 31 if this was less than the previously determined MIC or at half the MIC if this was lower than 10 Wg ml 31 .
Incorporation assays
The e¡ect of totarol on the synthesis of DNA and peptidoglycan was investigated using the incorporation of appropriate radioactively labelled precursors. For monitoring DNA synthesis, incorporation of radiolabelled thymidine (Amersham, UK; 1 WCi ml 31 , speci¢c activity 37 Mbq ml 31 ) was performed by the procedure of Powell et al. [14] . Growth of the cultures during the incorporation assay was monitored by total protein estimation, using the BioRad Protein microassay (Bio-Rad) on 0.5 ml lysed culture.
Incorporation of tritiated N-acetyl glucosamine (NAG) (Amersham, speci¢c activity 1.65 GBq mg 31 ) was used to measure the synthesis of peptidoglycan in the presence of increasing concentrations of totarol. [ 3 H]NAG was added to each culture to a ¢nal concentration of 2 WCi ml 31 . Samples were boiled in 10% SDS for 2 min to lyse the cells prior to being ¢ltered through glass ¢lters and washed with 1^2 ml sterile isotonic saline. Growth of the culture was monitored by determination of total cell protein.
Respiration measurements
An overnight culture of MRSA was diluted 50-fold in LB to give a ¢nal volume of 5 ml. The culture was grown shaking at 37³C until the OD 600 reached 0.6. The Clark-type oxygen electrode [15] was employed. When the oxygen consumption by the bacteria had reached a steady rate, measurement of respiration began.
When 5 or 10 min of steady-state respiration was achieved, diterpene was added to the chamber. The volume of diterpene added was always 17.5 Wl. Each concentration of diterpene was tested in triplicate. After the addition of diterpene, a further 10 min of steady-state respiration was measured.
Analysis of PBP 2a expression
An overnight culture of MRSA was diluted 1:50 to give four cultures each with a ¢nal volume of 6 ml. If induction with methicillin was performed, it was added at this time to a ¢nal concentration of 4 Wg ml 31 . All tubes were incubated with shaking at 37³C until the absorbance at 600 nm reached 0.4. When derivative 416 was added, this time, it was done to a ¢nal concentration of 4 Wg ml 31 . All tubes were further incubated for 60 min at 37³C with shaking. 1-ml samples were then removed and frozen. MSSA was also tested as a negative control of PBP 2a production.
Whole cell lysates were prepared from the samples described above by boiling in SDS. Proteins in the lysates were then separated in a 12.5% acrylamide gel containing SDS [16] Although totarol possessed the greatest independent activity, the three derivatives with the lowest MICs, derivatives 258, 390 and 416, were relatively similar in structure, all di¡ering from totarol by the addition of a single functional group. Derivative 258 was synthesised by the addition of a methyl alcohol group to totarol, derivative 390 was made by the addition of a hydroxyl group and derivative 416 differed from totarol by virtue of the addition of a methyl group to the parent compound. 
Potentiation of methicillin activity by diterpenes
The antibacterial activity of totarol may be potentiated by other natural products [4] . In addition, diterpenes have been described in a preliminary report [8] which signi¢cantly lowered the MIC of methicillin for MRSA. The MIC of methicillin against MRSA strain MR96/194 was determined to be 32 Wg ml 31 (Table 1 ). All nine compounds tested reduced the MIC of methicillin, by factors ranging from 4-fold to more than 256-fold in the case of derivative 416 (Table 1) . Similar magnitudes of MIC reduction have been reported by Chamberland and co-workers for a diterpene MC-200.616, larixyl acetate [8] . Those compounds which exhibited the best activity as potentiators of methicillin were also those that had the lowest MIC when tested independently.
Many S. aureus isolates are resistant to multiple antibiotics and in the USA, the mean prevalence rate of MRSA is 29% [10] . Given the requirement for new therapeutic agents for MRSA, the ability of diterpenes to potentiate the activity of existing antimicrobial compounds against MRSA is exciting. Joint administration of the microcide derivative with imipenem reduced the bacterial load by 3^4 logs in a mouse sub-cutaneous model of MRSA infection [9] , suggesting that potentiation of L-lactams in vivo may be su¤cient to clear infections.
The primary antibacterial e¡ect of totarol is not on DNA or peptidoglycan biosynthesis
It has been reported that totarol or related diterpene compounds may a¡ect production of macromolecules including DNA [3] and peptidoglycan [2] . As shown in Fig. 2 , no such direct inhibition was observed when incorporation of DNA or peptidoglycan precursors was measured as a function of cell pro- Fig. 1 . Structures of the most e¤cacious diterpenes used in this study. tein. Addition of levels of totarol approaching its MIC had no signi¢cant e¡ect relative to untreated controls. It has previously been reported that a related diterpene, pisiferic acid, was cytotoxic for eukaryotic cells at 2 Wg ml 31 and inhibited DNA polymerase K activity in HeLa cells around a threshold value of 33 Wg ml 31 [3] , which initially prompted us to examine the possible e¡ect of totarol on bacterial DNA synthesis in this study. Our data (Fig. 2) rule out bacterial DNA synthesis as a target for totarol (approaching MIC concentrations).
Totarol inhibits respiration of S. aureus
It has been reported that totarol inhibited respiration by bacterial cells and isolated membrane fractions of P. aeruginosa [6] . We therefore tested the e¡ect of increasing concentrations of totarol on the respiration rate of the MRSA strain relative to the untreated control. These data (Fig. 3) show that at half-MIC, totarol inhibited respiration 51% and by 70% at MIC. In contrast, 0.5UMIC (1 Wg ml 31 ) of totarol had no e¡ect on protein or peptidoglycan synthesis (Fig. 3) . We therefore conclude that this inhibition is likely to be a signi¢cant factor in the antibacterial action of the compound. This is consistent with the ¢ndings of Haraguchi and colleagues [6] . Further investigation will be required to de¢ne the site of action of totarol in the respiratory redox chain of S. aureus.
Potentiation of methicillin by diterpene is
independent of inhibition of respiration but may involve reduced PBP 2a production
Since totarol was shown to inhibit respiration and it increased bacterial susceptibility to methicillin, we investigated if, under potentiation conditions, there was any inhibition in respiration which might be a factor in making the bacteria more sensitive to the antibiotic. Methicillin alone (at sub-MIC levels) had expectedly no e¡ect on respiration (Fig. 4) and adding any of the ¢ve diterpenes at concentrations previously shown to reduce the methicillin MIC had no signi¢cant e¡ect on respiration rates. The 30% reduction in respiration rate observed for derivative 416 is not considered likely to be su¤cient to account for the dramatic sensitisation of MRSA to methicillin, but we cannot formally exclude some contribution. We therefore conclude that the potentiation of the action of methicillin is not sensitisation of bacterial cells by inhibition of respiration.
It has been reported that diterpenes may potentiate the L-lactam sensitivity of MRSA by interference with the expression or function of PBP 2a [8] . This observation was based upon functional detection of the PBP 2a protein using a biotinylated substrate (ampicillin). We detected a signi¢cant reduction in PBP 2a expression as a consequence of exposure to a diterpene (compound 416) which we had already shown to potentiate methicillin (Fig. 5) . Using a polyclonal antibody to detect PBP 2a, the expression of this protein was reproducibly reduced upon treatment of cells with sub-lethal concentrations of diterpene 416, but not to the same extent (almost total abolition) as the reduction in ampicillin binding reported by Chamberland and co-workers [8] . MSSA cells, as expected, did not produce PBP 2a. MRSA cells which had not previously been exposed to methicillin still produced readily detectable levels of PBP 2a, which was apparently una¡ected by exposure to the diterpene (Fig. 5, lanes 4 and 6) . The most signi¢cant reduction was evident from the comparison of methicillin-induced MRSA cells with or without exposure to derivative 416 (Fig. 5, lanes 3  and 5) , suggesting that the diterpene a¡ects induction or subsequent production of the novel PBP. The basal level of PBP 2a production in uninduced cells is insensitive to the diterpene, consistent with the hypothesis that de novo PBP 2a production is inhibited.
This study, with a limited panel of novel diterpene derivatives, has failed to identify more e¤cacious compounds than totarol, but has identi¢ed two compounds more e¡ective at lowering the methicillin MIC. We have provided further evidence for bacterial respiration as a target for the antibacterial activity of this potentially useful group of compounds, related members of which are available from sustainable resources such as common herbs [1] . In addition, continued identi¢cation of derivatives with a signi¢cant ability to reduce the MIC of currently ine¡ective antibiotics may expand the arsenal of therapeutic agents for signi¢cant pathogens such as MRSA.
